https://www.americanagingassociation.org/jobs
The American Aging Association is a group of experts dedicated to understanding the basic mechanisms of aging and the development of interventions in age-related disease to increase healthy lifespan for all.   
Mark your calendars for the AGE
45th Annual 
Meeting

June 3 through June 6, 2016

Seattle, WA

Targeting Aging:

The Ultimate Preventative Medicine




AGE
The Official Journal of the 
American Aging Association
Impact Factor 3.445

2015 Barshop Symposium on Aging

Metabolism and Aging: From Molecular Physiology to Systems Biology 

Keynote Speaker:

James Kirkland, M.D., Ph.D.

Conference Dates: October 15 – 18, 2015

Conference Location:  The Mayan Ranch, Bandera, Texas, located in the Texas Hill Country,

Located approximately 40 miles outside San Antonio, Texas       You will find the Required conference registration forms here




GSA’s 2015 Annual Scientific Meeting

Gain a 360 degree view of aging research, education, and practice. With 450 scientific sessions, this meeting will provide you with a multidisciplinary lens of the aging field. Discover what’s new in aging; view the Biological Sciences Program.

 

Be a part of the program, submit your Late Breaker Poster Session. Details to be posted this July.

 


Four recent Funding Opportunities Announcements issued by NIA or in which NIA participates.

  

1.   Characterization of Pro- and Anti-Geronic Proteins and Peptides (R01)  RFA-AG-16-005

Application Due Date: July 9, 2015

The goal of this FOA is to advance research on naturally occurring proteins (and/or peptides) known to impact one or more aging phenotypes, at physiological levels, based on whole-animal experimental evidence. These are "geronic proteins" isolated from circulation, which might reverse (rejuvenate) or potentially prevent development of aging phenotypes observable in an older laboratory animal, such as cardiac hypertrophy, diminished skeletal muscle repair-efficiency, reduced muscle strength, etc. (anti-geronic proteins), or which appear to promote an aging phenotype in a young adult laboratory animal, such as leading to decreased neurogenesis or cognitive function (pro-geronic proteins).

 http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-16-005.html

 

 

2.   T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21): PAR-15-190

Application Due Date: Standard dates apply

This funding opportunity announcement (FOA) encourages exploratory/developmental research projects to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. 

http://grants.nih.gov/grants/guide/pa-files/PAR-15-190.html

 

 

3.   Analyses of Human Datasets and Biospecimens to Characterize Aging-related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01): RFA-AG-16-012

Application Due Date: July 9, 2015

 This Funding Opportunity Announcement (FOA) invites applications to analyze existing datasets and stored biospecimens from human cohorts (e.g., epidemiologic studies, clinical trials) to advance understanding of potential effects in humans of polypeptides and proteins whose circulating levels change with age, and for which experimental evidence indicates reversal or acceleration of aging changes. 

http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-16-012.html

 

 

4.   Consortia for Innovative AIDS Research in Nonhuman Primates (UM1): RFA-AI-15-022

Application Due Date: July 29, 2015

This Funding Opportunity Announcement (FOA) solicits applications that will study a vaccine shown to have protected at least a subset of Nonhuman Primates (NHP) from lethal Simian Immunodeficiency Virus (SIV) or Simian-Human Immunodeficiency Virus (SHIV) mucosal challenge. 

http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-022.html